Tissue factor pathway inhibitor (TFPI) is a vital anticoagulation factor that inhibits factor Xa and factor VIIa to prevent prothrombotic diseases, including coronary artery disease (CAD) [9,10]. The gene discussed is F10; the disease is coronary artery disorder.